MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/clinem/dgaf681

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2026

The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysis.

Salvio Gianmaria, Ciarloni Alessandro, Aboud Nairus, Ambo Nicola, Bordoni Monia, Lucchetti Beatrice, Martino Marianna, Perrone Michele, Gasparroni Matteo, Balercia Giancarlo, Arnaldi Giorgio

СтатьяСистематический обзорМетаанализПеревод в очереди

Аннотация

INTRODUCTION

Cushing syndrome (CS) is a clinical condition caused by increased plasma cortisol levels and characterized by high cardiovascular mortality. Among the metabolic effects of CS and its treatment, glycemic disturbances have been investigated in depth, while data on dyslipidemia is still lacking.

OBJECTIVES

Our study aims at evaluating the effects of CS treatment on serum lipid levels.

MATERIALS AND

METHODS

A literature search was conducted using PubMed, Scopus, and EMBASE databases to investigate the effects of CS treatment on serum total cholesterol (TC), low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides. Before-after analysis and subgroup analysis were performed.

RESULTS

Twenty-nine observational or interventional studies (51.7% of good quality) were included in the quantitative analysis. Treatment of CS led to clinically and statistically significant decrease in serum TC (mean difference [MD] -26.49; 95% CI, -29.95 to -23.04; P < .00001), low-density lipoprotein cholesterol (MD -18.44; 95% CI, -21.30 to -15.57; P < .00001), and triglycerides levels (MD -17.77; 95% CI, -22.70 to -12.84; P < .00001), with no significant changes in high-density lipoprotein cholesterol levels (MD -2.34; 95% CI, -6.96 to 2.28; P = .32). Subgroup analysis showed greater decrease in TC levels in subjects with adrenal hypercortisolism, in those treated with steroidogenesis inhibitors, and in those with treatment duration ≥12 months. In addition, CS treatment significantly decreased blood glucose levels, body mass index, waist circumference, and insulin resistance index.

CONCLUSION

Our study demonstrates a significant improvement in serum lipid levels after treatment of CS. Because the cardiovascular complications of hypercortisolism depend on several factors, further studies are needed to determine whether this directly translates into an adequate reduction in the risk of major cardiovascular events.

Для цитирования: Salvio Gianmaria, Ciarloni Alessandro, Aboud Nairus, Ambo Nicola, Bordoni Monia, Lucchetti Beatrice, Martino Marianna, Perrone Michele, Gasparroni Matteo, Balercia Giancarlo, Arnaldi Giorgio. The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysis.. The Journal of clinical endocrinology and metabolism. 2026. DOI: 10.1210/clinem/dgaf681.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.